Skip to main navigation

Overview
Events & Presentations
News Releases
- For Global Media Only
- For U.S. Media Only
Corporate Governance
Stock
Financial & Filings

Events & Presentations

Events & Presentations

Upcoming Events

More events are coming soon.

Past Events

May 07, 2026 at 8:00 AM EDT

Q1 2026 Ascendis Pharma Earnings Conference Call

Click Here for Webcast

Presentations

May 6, 2026

PES 2026 ApproaCH 2-Year Subgroup Data

April 8, 2026

New Data: Phase 2 COACH Trial Week 52

March 16, 2026

ACMG 2026: ApproaCH Week 104 Data

March 2, 2026

YUVIWEL® (navepegritide) FDA Approval

January 9, 2026

44th Annual J.P. Morgan Healthcare Conference Presentation

January 8, 2026

COACH Trial Topline Week 52 Data

July 12, 2025

ENDO 2025: PaTHway 3-Year Data

June 9, 2025

COACH Trial Interim Topline Week 26 Data

May 15, 2025

ESPE & ESE 2025: PaTH Forward 4-Year Data

May 15, 2025

ESPE & ESE 2025: ApproaCH 52-Week Bone Morphometry

Pagination

Current page 1
Page 2
Page 3
Page 4
Next page
Last page

Shareholder Tools

RSS Feeds

Email Alerts

IR Contact

Footer Corporate Menu

TransCon
About us
Pipeline
Patients
Investors & News
Contact Us

Footer Copyrights Menu

Privacy Policy
Terms of Use

Ascendis, Ascendis Pharma, Ascendis Pharma logo, the company logo and TransCon are trademarks owned by the Ascendis Pharma group

© May 2026 Ascendis Pharma